IQVIA Holdings Inc. (IQV) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Durham, NC, United States. Der aktuelle CEO ist Ari Bousbib.
IQV hat IPO-Datum 2013-05-09, 89,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $29.75B.
IQVIA Holdings Inc. is a leading provider of advanced analytics, technology solutions, and clinical research services to the global life sciences industry across the Americas, Europe, Africa, and Asia-Pacific regions. The company operates through three primary business segments: Technology & Analytics Solutions, which delivers cloud-based applications and real-world evidence platforms; Research & Development Solutions, offering clinical trial management and laboratory services; and Contract Sales & Medical Solutions, providing healthcare provider engagement and medical affairs support. IQVIA serves pharmaceutical, biotechnology, device, diagnostic, and consumer health companies by enabling evidence generation, improving clinical outcomes, and optimizing commercial operations. Headquartered in Durham, North Carolina, the company was founded in 1982 and maintains strategic partnerships including a collaboration with HealthCore, Inc.
